Physician profile
Nathan E Smith
NPI 1912269796
$23,683.15
in general payments reported to CMS, 2019-2025
25 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,167 · 2020: $361 · 2021: $757 · 2022: $12K · 2023: $2,001 · 2024: $2,968 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,518 · Food and Beverage: $1,707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,518.22 |
| Food and Beverage | $1,706.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,805.44 | 2019-2023 | Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $2,186.92 | 2021-2024 | Advantagerib, Ribfix Blu Advantage, Sternalock Blu System |
| Atricure, INC. | $1,778.55 | 2019-2023 | |
| Medtronic Vascular, INC. | $1,537.87 | 2019 | |
| Edwards Lifesciences Corporation | $1,141.09 | 2019-2022 | |
| Gentleman Orthopedic Solutions | $511.96 | 2024 | |
| Abiomed | $507.53 | 2023-2025 | Impella |
| Artivion, INC. | $439.03 | 2019-2022 | |
| Arthrex, INC. | $302.65 | 2024 | |
| Baxter Healthcare | $259.38 | 2020 | |
| Silk Road Medical, INC. | $212.15 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic, INC. | $206.43 | 2021-2025 | Endurant Iis, Onyx Frontier |
| W. L. Gore & Associates, INC. | $142.83 | 2021 | |
| Cvrx, INC. | $131.82 | 2024 | Barostim Neo System |
| La Jolla Pharmaceutical Company | $124.48 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $93.93 | 2019 | |
| Abbott Laboratories | $84.22 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $45.05 | 2020-2023 | Xarelto |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $41.60 | 2025 | |
| Pfizer INC. | $39.73 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $21.24 | 2019 | |
| Boston Scientific Corporation | $20.59 | 2023 | Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.13 | 2024 | Lifevest |
| United Therapeutics Corporation | $15.70 | 2024 | Tyvaso |
| Terumo Medical Corporation | $13.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.